Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
S

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multiple Myeloma"

By Insights from 2023 ASH Annual Meeting FEATURING Sigrun Thorsteinsdottir
By Insights from 2023 ASH Annual Meeting FEATURING Sigrun Thorsteinsdottir
165 views
December 14, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

05:11
Pharmacosmos Hematology

A discussion on the safety of an IV iron replacement therapy

Feat. H. Bahrain
Myeloma
17:13

Updates From ASH: The Evolving Role and Sequencing of Bispecifics an…

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

245 views
08:11

Triple-Class-Exposed R/R MM: Results From the KarMMa-3 Trial of Ide-…

Insights from 2023 ASH Annual Meeting

K. Patel

185 views
19:08

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

870 views
04:30

High-Risk NDMM: KarMMa-2 Extended Follow-Up - Ide-Cel in HR-NDMM Pat…

Insights from 2023 ASH Annual Meeting

M. Alsina

121 views
16:42

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

H. Hashmi

1.6K views
19:24

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorpo…

Insights from 2023 ASH Annual Meeting

P. Richardson

760 views
06:44

ASH 2023 Insights: "Sonrotoclax Combined With Dexamethasone for the …

Insights from 2023 ASH Annual Meeting

H. Quach

71 views
06:55

ASH 2023 Insights: "Selinexor and Lenalidomide vs. Lenalidomide Main…

Insights from 2023 ASH Annual Meeting

H. Quach

28 views
05:03

ASH 2023 Insights: "Teclistamab in R/R MM - A Multi-Institutional Re…

Insights from 2023 ASH Annual Meeting

R. Chakraborty

236 views
15:13

ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With R/R …

Insights from 2023 ASH Annual Meeting

P. Richardson

139 views
09:05

RRMM: Effects of Ide-Cel vs. Standard Regimens on HRQoL in Patients …

Insights from 2023 ASH Annual Meeting

M. Delforge

174 views
09:39

ASH 2023 Insights: "Impact of Dex Dose Strength on Outcomes in NDMM"

Insights from 2023 ASH Annual Meeting

R. Banerjee

227 views
04:37

ASH 2023 Insights: "Early Peripheral Blood MRD Status by NGS in Pts …

Insights from 2023 ASH Annual Meeting

B. Derman

105 views
06:19

Dara-KRd in NDMM Without ASCT: Final Analysis of a Ph2 Trial

Insights from 2023 ASH Annual Meeting

B. Derman

760 views
12:32

ASH 2023 Insights: "Early Benefits and Psychological Effects of Scre…

Insights from 2023 ASH Annual Meeting

S. Rögnvaldsson

74 views
10:03

ASH 2023 Insights: "MGUS and the Risk of Thrombotic Events - Results…

Insights from 2023 ASH Annual Meeting

S. Rögnvaldsson

21 views
10:53

ASH 2023 Insights: "RVd vs. RVd Plus ASCT in African Americans With …

Insights from 2023 ASH Annual Meeting

J. Zonder

12 views
17:46

ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies on a …

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

1.4K views
08:36

ASH 2023 Insights: "Standard- and High-Risk ND Transplant-Eligible M…

Insights from 2023 ASH Annual Meeting

N. Joseph

463 views
10:06

ASH 2023 Insights: "Outcomes After CAR-T in MM Patients With Extrame…

Insights from 2023 ASH Annual Meeting

D. Pan

52 views
06:14

Multiple Myeloma: Inflammatory Biomarkers and Outcomes CAR T-Cell Th…

Insights from 2023 ASH Annual Meeting

D. Pan

72 views
12:37

ASH 2023 Insights: "GMMG ReLApsE Trial - Salvage Auto Transplant & L…

Insights from 2023 ASH Annual Meeting

M. Bärtsch

63 views
10:23

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long

148 views
07:27

ASH 2023 Insights: "Dual Targeting of SLAMF-7 and CD38 - A Ph2 Study…

Insights from 2023 ASH Annual Meeting

B. Dhakal

405 views
03:14

ASH 2023 Insights: "MyDRUG Sub-Protocol Y3 Results - Selinexor, Ixaz…

Insights from 2023 ASH Annual Meeting

J. Richter

126 views
08:51

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Specific A…

Insights from 2023 ASH Annual Meeting

R. Bansal

461 views
12:03

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed Stage…

Insights from 2023 ASH Annual Meeting

E. Kastritis

143 views
22:14

ASH 2023 Insights: "RW Safety & Efficacy of Teclistamab for Pts With…

Insights from 2023 ASH Annual Meeting

D. Dima

233 views
09:22

ASH 2023 Insights: "DREAMM-6 Trial Arm-A - Belantamab Mafodotin Comb…

Insights from 2023 ASH Annual Meeting

R. Popat

43 views
14:08

ASH 2023 Insights: "MonumenTAL-1 Study - Talquetamab in Pts With R/R…

Insights from 2023 ASH Annual Meeting

A. Jakubowiak

144 views
06:06

ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targ…

Insights from 2023 ASH Annual Meeting

S. Bal

69 views
04:55

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multi…

Insights from 2023 ASH Annual Meeting

S. Thorsteinsdottir

165 views
07:20

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and Dexam…

Insights from 2023 ASH Annual Meeting

O. Nadeem

92 views
10:36

ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies in H…

Insights from 2023 ASH Annual Meeting

O. Nadeem

98 views
11:55

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safe…

Insights from 2023 ASH Annual Meeting

O. Landgren

284 views